These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 19196556

  • 1. Epigenomic derangement of hepatic glucose metabolism by feeding of high fructose diet and its prevention by Rosiglitazone in rats.
    Yadav H, Jain S, Yadav M, Sinha PR, Prasad GB, Marotta F.
    Dig Liver Dis; 2009 Jul; 41(7):500-8. PubMed ID: 19196556
    [Abstract] [Full Text] [Related]

  • 2. Fructose-induced hepatic gluconeogenesis: effect of L-carnitine.
    Rajasekar P, Anuradha CV.
    Life Sci; 2007 Mar 06; 80(13):1176-83. PubMed ID: 17239403
    [Abstract] [Full Text] [Related]

  • 3. Effect of PPAR-gamma agonist on adiponectin levels in the metabolic syndrome: lessons from the high fructose fed rat model.
    Sharabi Y, Oron-Herman M, Kamari Y, Avni I, Peleg E, Shabtay Z, Grossman E, Shamiss A.
    Am J Hypertens; 2007 Feb 06; 20(2):206-10. PubMed ID: 17261469
    [Abstract] [Full Text] [Related]

  • 4. S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats.
    Sohn KA, Cruciani-Guglielmacci C, Kassis N, Clément L, Ouali F, Caüzac M, Lebègue N, Berthelot P, Caignard DH, Pégorier JP, Renard P, Dacquet C, Ktorza A, Magnan C, Consortium of the French Ministry of Research and Technology.
    Eur J Pharmacol; 2009 Apr 17; 608(1-3):104-11. PubMed ID: 19250932
    [Abstract] [Full Text] [Related]

  • 5. Roles for fructose-2,6-bisphosphate in the control of fuel metabolism: beyond its allosteric effects on glycolytic and gluconeogenic enzymes.
    Wu C, Khan SA, Peng LJ, Lange AJ.
    Adv Enzyme Regul; 2006 Apr 17; 46():72-88. PubMed ID: 16860376
    [Abstract] [Full Text] [Related]

  • 6. Myricetin, a naturally occurring flavonol, ameliorates insulin resistance induced by a high-fructose diet in rats.
    Liu IM, Tzeng TF, Liou SS, Lan TW.
    Life Sci; 2007 Nov 10; 81(21-22):1479-88. PubMed ID: 17976658
    [Abstract] [Full Text] [Related]

  • 7. Nateglinide prevents fatty liver through up-regulation of lipid oxidation pathway in Goto-Kakizaki rats on a high-fat diet.
    Mine T, Miura K, Kajioka T, Kitahara Y.
    Metabolism; 2008 Jan 10; 57(1):140-8. PubMed ID: 18078871
    [Abstract] [Full Text] [Related]

  • 8. Energy restriction enhances therapeutic efficacy of the PPARgamma agonist, rosiglitazone, through regulation of visceral fat gene expression.
    Moore GB, Pickavance LC, Briscoe CP, Clapham JC, Buckingham RE, Wilding JP.
    Diabetes Obes Metab; 2008 Mar 10; 10(3):251-63. PubMed ID: 18269641
    [Abstract] [Full Text] [Related]

  • 9. Hepatic effects of rosiglitazone in rats with the metabolic syndrome.
    Ackerman Z, Oron-Herman M, Pappo O, Peleg E, Safadi R, Schmilovitz-Weiss H, Grozovski M.
    Basic Clin Pharmacol Toxicol; 2010 Aug 10; 107(2):663-8. PubMed ID: 20210788
    [Abstract] [Full Text] [Related]

  • 10. Tissue-specific effects of rosiglitazone and exercise in the treatment of lipid-induced insulin resistance.
    Lessard SJ, Rivas DA, Chen ZP, Bonen A, Febbraio MA, Reeder DW, Kemp BE, Yaspelkis BB, Hawley JA.
    Diabetes; 2007 Jul 10; 56(7):1856-64. PubMed ID: 17440174
    [Abstract] [Full Text] [Related]

  • 11. Hepatic effects of a fructose diet in the stroke-prone spontaneously hypertensive rat.
    Brosnan MJ, Carkner RD.
    Am J Hypertens; 2008 Jun 10; 21(6):708-14. PubMed ID: 18437120
    [Abstract] [Full Text] [Related]

  • 12. Gravinol ameliorates high-fructose-induced metabolic syndrome through regulation of lipid metabolism and proinflammatory state in rats.
    Yokozawa T, Kim HJ, Cho EJ.
    J Agric Food Chem; 2008 Jul 09; 56(13):5026-32. PubMed ID: 18540612
    [Abstract] [Full Text] [Related]

  • 13. Westernized-like-diet-fed rats: effect on glucose homeostasis, lipid profile, and adipocyte hormones and their modulation by rosiglitazone and glimepiride.
    Schaalan M, El-Abhar HS, Barakat M, El-Denshary ES.
    J Diabetes Complications; 2009 Jul 09; 23(3):199-208. PubMed ID: 18407527
    [Abstract] [Full Text] [Related]

  • 14. Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet.
    Wada T, Kenmochi H, Miyashita Y, Sasaki M, Ojima M, Sasahara M, Koya D, Tsuneki H, Sasaoka T.
    Endocrinology; 2010 May 09; 151(5):2040-9. PubMed ID: 20211973
    [Abstract] [Full Text] [Related]

  • 15. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.
    Shih CC, Lin CH, Lin WL, Wu JB.
    J Ethnopharmacol; 2009 May 04; 123(1):82-90. PubMed ID: 19429344
    [Abstract] [Full Text] [Related]

  • 16. Effect of GCP-02, a PPARalpha/gamma dual activator, on glucose and lipid metabolism in insulin-resistant mice.
    Wang ZJ, Liu Q, Li PP, Zou CH, Shen ZF.
    Eur J Pharmacol; 2008 Feb 02; 580(1-2):277-83. PubMed ID: 18048028
    [Abstract] [Full Text] [Related]

  • 17. Discordance between intramuscular triglyceride and insulin sensitivity in skeletal muscle of Zucker diabetic rats after treatment with fenofibrate and rosiglitazone.
    Nadeau KJ, Ehlers LB, Aguirre LE, Reusch JE, Draznin B.
    Diabetes Obes Metab; 2007 Sep 02; 9(5):714-23. PubMed ID: 17697064
    [Abstract] [Full Text] [Related]

  • 18. Pioglitazone induces lipid accumulation in the rat heart despite concomitant reduction in plasma free fatty acid availability.
    Baranowski M, Blachnio-Zabielska A, Zabielski P, Gorski J.
    Arch Biochem Biophys; 2008 Sep 01; 477(1):86-91. PubMed ID: 18541139
    [Abstract] [Full Text] [Related]

  • 19. Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet.
    Shen KP, Lin HL, Hsieh SL, Kwan AL, Chen IJ, Wu BN.
    J Pharm Pharmacol; 2009 Apr 01; 61(4):517-25. PubMed ID: 19298700
    [Abstract] [Full Text] [Related]

  • 20. Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet.
    Fernandes-Santos C, Carneiro RE, de Souza Mendonca L, Aguila MB, Mandarim-de-Lacerda CA.
    Nutrition; 2009 Apr 01; 25(7-8):818-27. PubMed ID: 19268533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.